Time Burden of Cancer Care
Our goal is to learn about the time requirements of cancer care and
identify who is at greatest risk of negative effects and how we can mitigate these effects.
previous research
Current Research
Time toxicity of cancer: the time demands of cancer-related activities and their impact on well-being and quality of life
The time demands of cancer and its treatments are significant and take away from other activities important to individuals with cancer. Using automated sensor data, we will partner with the University of Alabama-Birmingham to measure objective cancer-related time use over a 28-day period, augmented by self-reported specific cancer activities, well-being, and quality of life to develop a scoring system of cancer-related time burden among adults with advanced ovarian or metastatic breast cancer.
We expect this project will have a positive impact by creating measures of cancer-related objective time use and subjective burden, enabling us to develop and measure the efficacy of future interventions to reduce cancer time demands.
Status: We are currently recruiting participants and collecting data.
Dr. Vogel and Dr. Julian Wolfson obtained R01 funding from the NIH National Cancer Institute for this work.
Current Research
App-Assisted Day Reconstruction to Reduce Treatment Burden and Logistic Toxicity in Cancer Patients
Cancer treatments often create numerous logistic challenges in prioritizing and managing treatment and everyday life priorities and how these challenges affect their everyday lives and well-being.
We are partnering with Daynamica Inc. to build and test an app for cancer patients to continuously monitor logistic toxicity in their daily lives. We hope to use this data to help Oncology clinical practices to reduce logistic toxicity.
Status: We are currently recruiting participants and collecting data.
Daynamica, Inc. received grant funding from the National Cancer Institute to support this research, partnering with the University of Minnesota, with Dr. Vogel as the site PI.
Related Publications
Click on the title to read the article.
- Etteldorf A, Sedhom R, Rotolo SM, Vogel RI, Booth CM, Blaes AH, Virnig BA, Dusetzina SB, Gupta A. The least costly pharmacy for cancer supportive care medications over time: the logistic toxicity of playing catch up. Support Care Cancer. 2022 Dec 13;31(1):3. doi: 10.1007/s00520-022-07472-x.
- Etteldorf A, Rotolo S, Sedhom R, Vogel RI, Blaes A, Dusetzina SB, Virnig B, Gupta A. Finding the Lowest-Cost Pharmacy for Cancer Supportive Care Medications: Not So Easy. JCO Oncol Pract. 2022 Aug;18(8):e1342-e1349. doi: 10.1200/OP.22.00051.
- Gu C, Jewett PI, Yabroff KR, Vogel RI, Parsons HM, Gangnon RE, Purani H, Blaes AH. Forgoing physician visits due to cost: regional clustering among cancer survivors by age, sex, and race/ethnicity. J Cancer Surviv. 2022 Mar 22:10.1007/s11764-022-01201-3. doi: 10.1007/s11764-022-01201-3.